Zhou et al.
301
C), 120.46 (5-C), 127.90 (ph), 130.00 (ph), 135.95 (ph),
140.67 (8-C), 145.07 (ph), 147.49 (4-C), 152.06 (2-C),
154.08 (6-C). MALDI-TOF MS: calcd.: 450.14 [MH]+;
found: 450.19.
Forskning), and the EU-FP6 funded RIGHT project (Project
no. LSHB-CT-2004–005276) is gratefully acknowledged.
References
1. A. Fire, S. Xu, M.K. Montgomery, S.A. Kostas, S.E. Driver,
and C.C. Mello, Nature (London), 391, 808 (1998).
2. S.M. Elbashir, J. Harborth, W. Lendechel, A. Yalcin, K.
Weber, and T. Tuschl. Nature (London), 411, 494 (2001).
3. C.B. Reese. Org. Biomol. Chem. 3, 3851 (2005).
4. S. Pitsch, P.A. Weiss, L. Jenny, A. Stutz, X. Wu, and H.C.
Acta. Helv. Chim. Acta, 84, 3773 (2001).
N3-(4-tolylsulfonylethyl) uridine (12) (UN3-TSE
)
HPLC analysis of the reaction mixture showed that 57.2%
of the uridine was transformed to product 12 and 34.1% of
the uridine was unreacted. CC (DCM, MeOH from 5% to
1
7%). H NMR (270 MHz, CDCl3 + CD3OD) δ: 2.39 (s, 3H,
PhMe), 3.42 (t, J = 7.0 Hz, 2H, SO2CH2), 3.76 (dd, J =
12.2 Hz, 2H, 5′,5′′-H), 3.99 (d, J = 1.5 Hz, 1H, 4′-H), 4.10–
4.21 (m, 4H, 2′, 3′, -H, SO2CH2CH2), 5.65 (d, J = 8.1 Hz,
1H, 5-H), 5.72 (d, J = 2.3 Hz, 1H, 1-H), 7.32 (d, J = 7.8 Hz,
2H, phH), 7.74 (d, J = 8.2 Hz, 2H, phH), 7.85 (d, J =
8.1 Hz, 1H, 6-H). 13C NMR (67.9 MHz, CDCl3 + CD3OD)
δ: 23.88 (PhMe), 34.95 (SO2CH2CH2) 52.56 (SO2CH2CH2),
60.95 (5′-C), 69.41 (3′-C), 74.73 (2′-C), 85.16 (4′-C), 91.13
(1′-C), 101.40 (5-C), 128.04 (ph), 130.11 (ph), 135.67 (ph),
139.81 (6-C), 145.36 (ph), 150.92 (2-C), 162.60 (4-C).
MALDI-TOF MS: calcd.: 427.11 [MH]+; found: 427.15.
5. S.A. Caringe, F.E. Wincott, and M.H. Caruthers. J. Am. Chem.
Soc. 120, 11820 (1998).
6. A. Semenyuk, A. Foldesi, T. Johansson, C. Estmer-Nilsson, P.
Blomgren, M. Brannvall, L.A. Kirsebom, and M.
Kwiatkowski. J. Am. Chem. Soc. 128, 12356 (2006).
7. T. Ohgi, Y. Masutomi, K. Ishiyama, H. Kitagawa, Y. Shiba,
and J. Yano. Org. Lett. 7, 3477 (2005).
8. C.Z. Zhou, D. Honcharenko, and J. Chattopadhyaya. Org.
Biomol. Chem. 5, 333 (2007).
9. J.J. Solomon, I.L. Cote, M. Wortman, K. Decker, and A. Segal.
Chem. Biol. Interactions, 51, 167 (1984).
10. J.W. Jones and R.K. Robins. J. Am. Chem. Soc. 85, 193 (1963).
11. P.D. Lawley and P. Brookes. Biochem. J. 127 (1963).
12. M. Mag and J.W. Engels. Nucleic Acids Res. 16, 3525 (1988).
13. P. Brookes, and P.D. Lawley. J. Chem. Soc. 1348 (1962).
14. R.L.C. Brimacombe, B.E. Griffin, J.A. Haines, W.J. Haslam,
and C.B. Reese. Biochemistry, 4, 2452 (1965).
15. K.K. Ogilvie and S.L. Beaucage. Nucleic Acids Res. 7, 805
(1979).
16. T. Umemoto and T. Wada. Tetrahedron Lett. 46, 4521 (2005).
17. D.C. Capaldi, H. Gaus, A.H. Krotz, J. Arnold, R.L. Carty,
M.N. Moore, A.N. Scozzari, K. Lowery, D.L. Cole, and V.T.
Ravikumar. Org. Process Res. Dev. 832 (2003).
N2-(4-tolylsulfonylethyl) guanosine (13) (GN2-TSE
)
HPLC analysis of the reaction mixture showed that 50.3%
of the guanosine was transformed to product 13 and 23.8%
of the guanosine was unreacted. The product 13 was too po-
lar to purify by silica gel column chromatography, hence
preparative HPLC was used to purify a small amount of
1
product 13 for NMR and MS analysis. H NMR (270 MHz,
DMSO-d6) δ: 2.38 (s, 3H, PhMe), 3.51–3.60 (m, 6H,
SO2CH2, SO2CH2CH2, 5′,5′′-H), 3.99 (t, J = 1.5 Hz, 1H, 4′-
H), 4.11 (t, 1H, 3′-H), 4.47 (t, J = 5.3 Hz, 1H, 2′-H), 5.68
(d, J = 5.8 Hz, 1H, 1′-H), 6.88 (br., 1H, N2H), 7.42 (d, J =
7.9 Hz, 2H, phH), 7.77 (d, J = 8.2 Hz, 2H, phH), 7.93 (s,
1H, 8-H), 10.94 (br., 1H, N1H). 13C NMR (67.9 MHz,
DMSO-d6) δ: 21.64 (PhMe), 34.95 (SO2CH2CH2) 54.11
(SO2CH2CH2), 62.11 (5′-C), 70.99 (3′-C), 74.27 (2′-C),
85.87 (4′-C), 87.21 (1′-C), 117.70 (5-C), 128.17 (ph), 130.43
(ph), 136.46 (8-C), 136.70 (ph), 144.96 (ph), 151.06 (4-C),
152.89 (2-C), 157.67 (6-C). MALDI-TOF MS: calcd.:
466.23 [MH]+; found: 466.13.
18. B. J. Pullman. Chem. Soc. B, 1621 (1959).
19. J. Ofengand. Methods Enzymol. 20, 162 (1971).
20. A. Segal, U. Mate, and J.J. Solomon. Chem. Biol. Interactions,
28, 333 (1979).
21. J.D. Engel. Biochem. Biophys. Res. Comm. 64, 581 (1975).
22. R. Micura, W. Pils, C. Höbartner, K. Grubmayr, M.O. Ebert,
and B. Jaun. Nucleic Acids Res. 29, 3997 (2001).
23. H.M. Kong, L.F. Lin, N. Porter, S. Stickel, D.P.J. Byrd, and
R.J. Roberts. Nucleic Acids Res. 28, 3216 (2000).
24. O. Gorchs, M. Mernandez, L. Garriga, E. Pedroso, A.
Grandas, and J. Farras. Org. Lett. 4, 1827 (2002).
25. C. Höbartner, C. Kreutz, E. Flecker, E. Ottenschlager, W. Pils,
K. Grubmayr, and R. Micura. Monatsh. Chem. 134, 851 (2003).
26. M. Beier, and W. Pfleiderer. Helv. Chim. Acta, 86, 2533 (2003).
27. S.T. McDowell, C.J.M. Stirling. J. Chem. Soc. B, 343 (1967).
28. S.T. McDowell and C.J.M. Stirling. J. Chem. Soc. B, 348
(1967).
Base composition analysis
Shrimp alkaline phosphatase and phosphodiesterase I
(Crotalus adamanteus venom) were purchased from
Amersham Pharmacia Biotech, Sweden. A reaction mixture
containing 20 mmol/L Tris-HCl (pH 8.0), 10 mmol/L MgCl2,
shrimp alkaline phosphatase (0.5 unit), and phosphodiester-
ase I (Crotalus adamanteus venom) (0.4 unit) was added to
oligoribonucleotide (0.1 OD unit at 260 nm) with a total re-
action volume of 30 µL. The reaction mixture was incubated
at 37 °C for 12 h and subjected to HPLC analysis directly.
29. S.T. McDowell and C.J.M. Stirling. J. Chem. Soc. B, 351
(1967).
30. D.D. Perrin. Dissociation constants of organic bases in aque-
ous solution. Supplement. Butterworths, London, UK. 1972.
31. F. Wincott, A. DiRenzo, C. Shaffer, S. Grimm, D. Tracz, C.
Workman, D. Sweedler, C. Gonzalez, S. Scaringe, and N.
Usman. Nucleic Acids Res. 23, 2677 (1995).
32. Handbook of gel filtration, principles and methods. Edited by
Acknowledgements
Amersham Biosciences.
33. J. Milecki, E. Zamaratski, T.V. Maltseva, A. Földesi, R.
Adamiak, and J. Chattopadhyaya. Tetrahedron Lett. 55, 6603
(1999).
Generous financial support from the Swedish Natural Sci-
ence Research Council (Vetenskapsr et), the Swedish Foun-
dation for Strategic Research (Stiftelsenf Strategisk
© 2007 NRC Canada